Casey co-founded Sleep Management, now VieMed, with the objective of becoming the leading respiratory disease management company in the United States. His goal has been to enable patients to live better lives through clinical excellence, education and technology. Casey has also successfully managed several other businesses, most recently a worldwide organization offering a comprehensive line of tradeshow display and marketing services . After selling VieMed to PHM, Casey became Chief Executive Officer.
Managing Director, Disease Management
Mike co-founded Sleep Management, now VieMed, and brought his clinical and healthcare expertise to the table. He began his career first as a Respiratory Therapist and later transitioned to Account Executive, with organizations such as Praxair and Home Care Supply, where he continually exceeded sales goals and finished in the top 5 nationally of all AE’s. Mr. Moore’s experience as a clinician, as well as his knowledge of healthcare trends, played a key role in formulating the strategy that enabled VieMed to become the diverse respiratory-focused company that it is today. After selling the company to PHM, Mike became President.
Chief Compliance Officer
Brett Stoute joined VieMed in 2007 and was involved in the early developmental stages integral to the organizations expansion. Mr. Stoute is a member of the Executive Management team and is in charge of the daily operation, ensuring that patients are serviced in a timely and effective manner while also overseeing administrative functions.
Mr. Stoute is a former member of the Medicare DMERC Supplier Advisory Committee for Region C. He has 23 years of experience in the healthcare industry serving in the roles of HME sales, management and ownership. Mr. Stoute obtained a Bachelor of Science degree in Management and currently resides in Lafayette, Louisiana.
Managing Director, DME
Mr. Crawford joined PHM through PHM’s purchase of Patient-Aids, Inc. last year. Mr. Crawford began working at Patient-Aids in 1994, becoming a partner 3-years later and Patient-Aids’ sole owner in 2004. During the period of his ownership, Patient-Aids grew at an annual rate of approximately 25% and from 2013 through 2015 more than doubled its revenue and quadrupled its earnings as it acquired and successfully integrated 5 home medical equipment (“HME”) businesses.
Board of Directors
Mr. Dalsin is a former Managing Director of Stanmore Capital Partners, Inc., a healthcare services specialized investment firm. Previous to Stanmore, Mr. Dalsin worked in international investment banking and deal-making with investments by Morgan Stanley Managing Director’s funds in London, Hong Kong and New York. He has participated as a lead banker and negotiator for a number of small and medium market ($25M to $100M) international roll-ups for both American and English companies. He holds an economics degree from University of Wisconsin – Madison.
Mr. Kaushal has worked in senior roles with a number of Canadian investment banks focused on healthcare, including Desjardins Securities Inc, Orion Securities Inc, Vengate Capital, HSBC Securities Inc and Gordon Capital. He has held roles within the private equity/venture capital industry at MDS Capital Corp. and at PricewaterhouseCoopers in their M&A, valuation and audit groups. In addition, Mr. Kaushal has sat on a number of public and private company boards. He was awarded a Bachelor of Science (Chemistry) from the University of Toronto and is a Chartered Accountant.
Mr. Greene is a former Managing Director of Stanmore Capital Partners, Inc. He holds a BA in economics from Harvard College and a law degree from Harvard Law School. Mr. Greene worked with the various funds in the Robert M. Bass Group in Texas as a principal and as general counsel. He participated in a number of their opportunity funds, including Brazos Fund, which purchased $2 billion in assets in the US and Canada, and Lone Star Fund, which has acquired and managed several billions of dollars in assets in North America, Asia and Europe. For Brazos, Mr. Greene was responsible for negotiations on a $300 million purchase of assets from a thrift in Canada, a roll-up of assets of over $100 million that resulted from the merger of two insurance companies, and the securitization of hundreds of millions of dollars of loans.